CP Kelco
ATLANTA, 2015-09-16 17:00 CEST (GLOBE NEWSWIRE) --
In response to the strong global demand for specialty Biogums products, CP Kelco today announced plans to invest in building capabilities and expanding production capacity.
As a leading global producer of hydrocolloid solutions used in a wide range of consumer products and industrial applications, CP Kelco is reinforcing its commitment to three Biogums product lines – gellan gum, specialty xanthan gum and diutan gum – through these key operational initiatives:
- Expanding capacity for gellan gum beyond CP Kelco’s existing San Diego, California plant with additional production line capability in the company’s Okmulgee, Oklahoma facility;
- Developing new capabilities for specialty xanthan gum production in the company’s Wulian, China facility;
- Exploring options for further expansion of CP Kelco’s Biogums manufacturing footprint
In addition to the investments in new capabilities and production capacity, CP Kelco is equally committed to ensuring its Biogums products meet the high standards of quality and food safety established for all industry segments it serves. “As regulatory requirements related to our products increase, CP Kelco will continually invest in operational and innovative developments to help ensure we can meet or exceed our customers’ expectations,” said Don Rubright, President of CP Kelco.
About CP Kelco
Headquartered in Atlanta, Georgia, USA, CP Kelco is a leading producer of specialty hydrocolloids with offices and facilities across the globe. Featuring an extensive range of hydrocolloid solutions and serving over 100 countries, CP Kelco leverages its capabilities to bring concepts and ideas to real-world products in a broad range of applications. The company’s specialty ingredients touch a wide variety of industrial applications, consumer and household products, tailored to meet the needs of regional consumers. Key product lines areGellan Gum,Pectin, Diutan Gum,Xanthan Gum,Carrageenan,Carboxymethyl CelluloseandMicroparticulated Whey Protein Concentrate, as well as other unique biopolymers. Visitwww.cpkelco.comfor more information.
CONTACT:
Michele Cacdac-Jones
Director of Global Communications
Office: +1 678 247 7149
michele.cacdac-jones@cpkelco.com
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Globenewswire
F. Hoffmann-La Roche Ltd21.7.2025 07:00:00 CEST | Press release
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on astegolimab in chronic obstructive pulmonary disease
Scandinavian Investment Group A/S20.7.2025 21:21:16 CEST | Pressemeddelelse
Aktietilbagekøb 15-18 juli 2025
Ulanzi (VIJIM LIMITED)20.7.2025 16:13:45 CEST | Press release
Ulanzi Named Global No.1 in Camera Accessories Sales Volume for 2024 by Frost & Sullivan
TERA-Award20.7.2025 16:00:00 CEST | Press release
Fourth TERA-Award Ceremony held in Cambridge
Zealand Pharma18.7.2025 18:30:00 CEST | Press release
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum